Unresectable Urothelial Carcinoma
📧 Sign up to get email alerts when something new happens for Unresectable Urothelial Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: A Study Comparing the Combination of Pembrolizumab and Sacituzumab Govitecan Versus Standard of Care in the Treatment of Advanced Urothelial Cancer [Phase 3]
This Phase 3 trial is evaluating pembrolizumab plus sacituzumab govitecan versus standard of care for locally advanced, unresectable, or met…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Pembrolizumab Plus CA-4948 for the Treatment of Patients With Progressive Metastatic Urothelial Cancer Despite Prior Immunotherapy [Phase 1]
Phase 1 clinical trial evaluating pembrolizumab in combination with CA-4948 for progressive metastatic urothelial cancer, currently recruiti…
-
CLINICAL_TRIALS research · 2026-02-19Clinical Trial Update: Pembrolizumab Maintenance After Enfortumab Vedotin (EV)/Pembro Induction in Front-Line Metastatic Urothelial Carcinoma [Phase 2]
Phase 2 trial evaluating pembrolizumab maintenance after enfortumab vedotin/pembrolizumab induction as front-line treatment for metastatic u…